Targeting Hims & Hers, F.D.A. Takes on a New Type of Drug Advertiser
Regulators sent about 100 warning letters this week to drug [...]
Trump Moves to Crack Down on Drug Advertising
The administration is proposing a return to a 1990s-era policy [...]
Wegovy Gets F.D.A. Approval for MASH
Wegovy has been approved for use among the growing number [...]
How Ozempic Maker Novo Nordisk Lost Its Shine
The pioneering Danish drugmaker was once the most valuable company [...]
Novo Nordisk, Ozempic Drugmaker, Sees Stock Plunge 20% After Profit Warning
Novo Nordisk slashed its financial forecasts as it struggled to [...]
Novo Nordisk to Replace C.E.O. After Losing Edge in Weight-Loss Drugs
The Danish drugmaker, which makes Ozempic and Wegovy, has seen [...]
Why Patients Are Being Forced to Switch to a 2nd-Choice Obesity Drug
CVS Caremark decided to stop offering Zepbound in favor of [...]
What to Know About Eli Lilly’s Daily Pill for Weight Loss
Eli Lilly reported promising results from a study of its [...]
Patients Cut Off From Cheaper Obesity Drugs as FDA Halts Sales of Copycats
U.S. regulators are trying to shut down the industry for [...]
Trump Rejects Proposal for Medicare to Cover Wegovy and Other Obesity Drugs
Administration officials reversed a decision made during the Biden presidency [...]